Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
281
1.740
Why?
Carcinoma, Squamous Cell
15
2010
330
1.650
Why?
DNA Methylation
13
2009
546
1.120
Why?
DNA Glycosylases
5
2011
19
1.050
Why?
Gene Silencing
7
2009
114
1.040
Why?
Promoter Regions, Genetic
11
2009
466
1.040
Why?
Mitochondria
3
2011
398
0.520
Why?
DNA Repair
5
2008
186
0.510
Why?
Adaptor Proteins, Signal Transducing
5
2009
197
0.480
Why?
Polymerase Chain Reaction
11
2009
456
0.480
Why?
Kidney Neoplasms
2
2008
173
0.470
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
154
0.460
Why?
DNA, Neoplasm
10
2008
146
0.460
Why?
Nuclear Proteins
5
2009
242
0.460
Why?
Neoplasm Proteins
4
2005
321
0.410
Why?
Laryngeal Neoplasms
3
2007
42
0.390
Why?
Vascular Endothelial Growth Factor A
2
2009
183
0.370
Why?
CpG Islands
3
2008
106
0.370
Why?
Lung Neoplasms
2
2007
601
0.350
Why?
Microsatellite Instability
1
2009
18
0.340
Why?
Fatty Liver
1
2011
128
0.340
Why?
Immunohistochemistry
7
2012
973
0.330
Why?
Mitochondrial Proteins
2
2007
88
0.320
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
22
0.320
Why?
Port-Wine Stain
1
2008
14
0.310
Why?
Oxygen
1
2011
321
0.300
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
9
0.300
Why?
Genes, p16
3
2005
9
0.290
Why?
Lymph Nodes
2
2007
258
0.290
Why?
DNA, Mitochondrial
4
2011
110
0.290
Why?
N-Glycosyl Hydrolases
1
2007
6
0.290
Why?
Carcinoma, Renal Cell
1
2008
101
0.280
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
15
0.280
Why?
Skin
3
2010
416
0.280
Why?
Aged
15
2011
9505
0.280
Why?
Adenoma
1
2008
111
0.280
Why?
Mitochondria, Liver
1
2007
69
0.280
Why?
Cisplatin
3
2007
275
0.270
Why?
Proteoglycans
2
2003
81
0.260
Why?
Fibroma
1
2006
39
0.260
Why?
Aged, 80 and over
8
2009
3158
0.250
Why?
Liver
1
2011
1122
0.250
Why?
Membrane Glycoproteins
2
2003
244
0.240
Why?
Middle Aged
16
2011
12356
0.240
Why?
Survival Analysis
5
2009
670
0.240
Why?
Carcinoma, Hepatocellular
1
2007
196
0.230
Why?
Humans
36
2013
50201
0.230
Why?
Prognosis
7
2007
1963
0.230
Why?
DNA Repair Enzymes
1
2004
42
0.230
Why?
Ataxia Telangiectasia
1
2004
6
0.230
Why?
Salivary Ducts
1
2003
3
0.230
Why?
Salivary Gland Neoplasms
1
2003
7
0.230
Why?
Adenocarcinoma, Clear Cell
1
2003
34
0.220
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
65
0.220
Why?
Liver Neoplasms
1
2007
331
0.210
Why?
Obesity
1
2011
1112
0.210
Why?
Adult
14
2011
13486
0.200
Why?
Nitric Oxide Synthase Type III
2
2013
78
0.200
Why?
Female
22
2012
26829
0.200
Why?
Male
21
2012
25572
0.190
Why?
Epigenesis, Genetic
1
2004
371
0.180
Why?
Transcription Factors
1
2003
563
0.170
Why?
Antineoplastic Agents
2
2010
1176
0.170
Why?
Skin Transplantation
2
2010
43
0.160
Why?
Skin Neoplasms
4
2008
487
0.160
Why?
Carrier Proteins
4
2005
302
0.160
Why?
Tumor Suppressor Proteins
2
2011
127
0.150
Why?
Loss of Heterozygosity
2
2008
77
0.150
Why?
DNA Damage
2
2011
300
0.140
Why?
Survival Rate
3
2009
906
0.140
Why?
Neoplasm Invasiveness
4
2007
269
0.130
Why?
Graft Survival
3
2011
153
0.120
Why?
Ki-67 Antigen
2
2011
57
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
579
0.120
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
34
0.120
Why?
Algorithms
2
2008
615
0.120
Why?
Immunoenzyme Techniques
4
2013
141
0.110
Why?
Cadherins
2
2005
64
0.110
Why?
Prostatic Neoplasms
2
2008
393
0.110
Why?
Thyroid Neoplasms
2
2007
113
0.110
Why?
Keratosis
2
2003
14
0.110
Why?
Receptors, Cell Surface
1
2013
120
0.100
Why?
Base Sequence
2
2004
653
0.100
Why?
Carcinoma in Situ
2
2003
73
0.100
Why?
Lymphangioma, Cystic
1
2011
10
0.100
Why?
Laryngectomy
3
2007
27
0.100
Why?
Arteriovenous Malformations
1
2013
68
0.100
Why?
Leukoplakia, Oral
1
2011
6
0.100
Why?
Aminolevulinic Acid
1
2011
8
0.100
Why?
Endothelium, Lymphatic
1
2011
12
0.100
Why?
Lasers, Dye
1
2011
10
0.100
Why?
Wound Healing
2
2010
203
0.100
Why?
Antigens, CD
1
2013
216
0.100
Why?
Cell Line, Tumor
4
2010
1390
0.100
Why?
Photosensitizing Agents
1
2011
19
0.100
Why?
Propranolol
1
2012
78
0.100
Why?
Lymphatic Abnormalities
1
2011
22
0.100
Why?
Microtubule-Associated Proteins
1
2011
65
0.090
Why?
Photochemotherapy
1
2011
33
0.090
Why?
Biopsy
3
2011
592
0.090
Why?
Homeodomain Proteins
1
2011
86
0.090
Why?
Laser Therapy
1
2011
84
0.090
Why?
Taxoids
1
2010
37
0.090
Why?
Drug Resistance, Multiple
1
2010
24
0.090
Why?
Hemangioma
1
2012
84
0.090
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
55
0.090
Why?
Follow-Up Studies
4
2011
2188
0.090
Why?
Gene Deletion
1
2011
267
0.090
Why?
Neoplasm Staging
3
2007
749
0.080
Why?
Gene Expression Regulation, Neoplastic
4
2010
824
0.080
Why?
Mice, Transgenic
1
2011
542
0.080
Why?
Disease Models, Animal
2
2011
1419
0.080
Why?
Animals
8
2011
13141
0.080
Why?
Paraffin Embedding
1
2008
52
0.080
Why?
Sulfites
1
2008
1
0.080
Why?
Drug Resistance, Neoplasm
1
2010
315
0.080
Why?
Microsatellite Repeats
1
2008
37
0.080
Why?
Blood Glucose
1
2011
434
0.080
Why?
Mice
4
2011
5673
0.080
Why?
Neoplasm Seeding
1
2008
4
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1000
0.080
Why?
Chordoma
1
2008
8
0.080
Why?
Skull Base Neoplasms
1
2008
20
0.070
Why?
Recurrent Laryngeal Nerve
1
2007
12
0.070
Why?
Laryngeal Nerves
1
2007
15
0.070
Why?
Receptors, Thyrotropin
1
2007
7
0.070
Why?
Apoptosis Regulatory Proteins
2
2005
85
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
60
0.070
Why?
Symporters
1
2007
17
0.070
Why?
Methylation
2
2007
118
0.070
Why?
Pattern Recognition, Automated
1
2007
41
0.070
Why?
Image Enhancement
1
2007
54
0.070
Why?
Cell Proliferation
1
2011
987
0.070
Why?
Risk Factors
3
2008
3644
0.070
Why?
Precancerous Conditions
1
2008
83
0.070
Why?
Prostate
1
2008
117
0.070
Why?
Carcinoma, Papillary
1
2007
49
0.070
Why?
Transgenes
1
2007
52
0.070
Why?
Child, Preschool
3
2012
3896
0.070
Why?
Image Interpretation, Computer-Assisted
1
2007
105
0.070
Why?
Child
5
2012
6862
0.070
Why?
Neoplasm Recurrence, Local
2
2008
630
0.070
Why?
MicroRNAs
1
2010
349
0.070
Why?
Cell Nucleus
1
2007
186
0.070
Why?
Syndecans
2
2003
34
0.070
Why?
RNA, Messenger
2
2007
1097
0.070
Why?
Protein Transport
1
2007
183
0.070
Why?
Syndecan-1
2
2003
72
0.070
Why?
Artificial Intelligence
1
2007
84
0.070
Why?
Genomics
1
2008
284
0.070
Why?
Adenomatous Polyposis Coli Protein
1
2005
2
0.060
Why?
Receptors, Atrial Natriuretic Factor
1
2005
8
0.060
Why?
Atrial Natriuretic Factor
1
2005
25
0.060
Why?
Ear, Inner
1
2005
18
0.060
Why?
Melanoma
1
2008
281
0.060
Why?
Guanine
1
2004
40
0.060
Why?
Cell Physiological Phenomena
1
2004
3
0.060
Why?
Cell Cycle Proteins
1
2005
166
0.060
Why?
Cytochromes c
1
2003
28
0.060
Why?
DNA Adducts
1
2004
79
0.060
Why?
Salivary Proteins and Peptides
1
2003
8
0.060
Why?
Statistics as Topic
1
2003
88
0.050
Why?
Isoenzymes
1
2003
168
0.050
Why?
Base Pair Mismatch
1
2003
22
0.050
Why?
Adenocarcinoma, Follicular
1
2003
4
0.050
Why?
Adenocarcinoma, Papillary
1
2003
5
0.050
Why?
Tunica Intima
1
2003
55
0.050
Why?
Adenoma, Oxyphilic
1
2003
11
0.050
Why?
Cell Count
1
2003
147
0.050
Why?
Retrospective Studies
4
2007
6190
0.050
Why?
DNA-Binding Proteins
1
2005
424
0.050
Why?
Keratoacanthoma
1
2002
7
0.050
Why?
Collagen
1
2003
208
0.050
Why?
Renal Dialysis
1
2003
171
0.050
Why?
Alcohol Drinking
1
2003
221
0.050
Why?
Platelet Aggregation Inhibitors
1
2003
174
0.050
Why?
Combined Modality Therapy
4
2004
639
0.050
Why?
Molecular Sequence Data
1
2003
795
0.050
Why?
Lung
1
2005
507
0.050
Why?
Blotting, Western
2
2013
587
0.050
Why?
Cohort Studies
1
2005
1414
0.050
Why?
Adolescent
2
2012
6459
0.050
Why?
Blood Platelets
1
2003
252
0.050
Why?
Prevalence
1
2004
960
0.050
Why?
Tomography, X-Ray Computed
1
2006
1160
0.040
Why?
Smoking
1
2003
506
0.040
Why?
Random Allocation
2
2010
288
0.040
Why?
Quality of Life
1
2004
843
0.040
Why?
Electrophoresis, Agar Gel
2
2008
12
0.040
Why?
Sensitivity and Specificity
2
2010
871
0.030
Why?
Hyperplasia
2
2008
96
0.030
Why?
Neck Dissection
2
2008
30
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1356
0.030
Why?
Fluorouracil
2
2004
55
0.030
Why?
Photosensitivity Disorders
2
2003
10
0.030
Why?
Cross-Sectional Studies
2
2012
1580
0.030
Why?
Infant
2
2012
3584
0.030
Why?
Lymph Node Excision
2
2004
138
0.030
Why?
Head
1
2013
70
0.030
Why?
Actins
1
2013
115
0.030
Why?
Neck
1
2013
99
0.030
Why?
Treatment Outcome
3
2011
5203
0.020
Why?
Lymphocele
1
2011
7
0.020
Why?
Tissue Survival
1
2011
10
0.020
Why?
Antigens, Nuclear
1
2011
24
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
47
0.020
Why?
Tissue Culture Techniques
1
2011
37
0.020
Why?
Transplantation, Heterologous
1
2011
75
0.020
Why?
Administration, Topical
1
2011
57
0.020
Why?
Time Factors
2
2010
2909
0.020
Why?
Mice, Nude
1
2011
252
0.020
Why?
Neoplasms, Squamous Cell
1
2010
7
0.020
Why?
Rats
2
2009
3277
0.020
Why?
Pharmacogenetics
1
2010
50
0.020
Why?
Granulation Tissue
1
2010
10
0.020
Why?
Tissue and Organ Harvesting
1
2010
23
0.020
Why?
Myeloid Cells
1
2010
37
0.020
Why?
Probability
1
2010
164
0.020
Why?
Endothelial Cells
1
2011
257
0.020
Why?
Carcinoma
1
2010
139
0.020
Why?
Graft Rejection
1
2010
168
0.020
Why?
Pilot Projects
1
2011
703
0.020
Why?
Neovascularization, Physiologic
1
2009
68
0.020
Why?
Thymine
1
2008
10
0.020
Why?
Chi-Square Distribution
1
2009
280
0.020
Why?
Centromere
1
2008
13
0.020
Why?
Microdissection
1
2008
19
0.020
Why?
Cell Line, Transformed
1
2008
73
0.020
Why?
Telomere
1
2008
36
0.020
Why?
Melanocytes
1
2008
38
0.020
Why?
Gene Dosage
1
2008
78
0.020
Why?
Fluorescent Dyes
1
2008
105
0.020
Why?
Iodine
1
2007
10
0.020
Why?
Genetic Markers
1
2008
103
0.020
Why?
Predictive Value of Tests
1
2010
921
0.020
Why?
Mice, Knockout
1
2010
840
0.020
Why?
Fatal Outcome
1
2008
195
0.020
Why?
Cluster Analysis
1
2007
233
0.020
Why?
Epithelial Cells
1
2008
210
0.020
Why?
Buffers
1
2005
9
0.020
Why?
Prospective Studies
1
2011
2396
0.020
Why?
Round Window, Ear
1
2005
6
0.020
Why?
Rats, Inbred Lew
1
2005
43
0.020
Why?
Injections
1
2005
57
0.020
Why?
Phosphates
1
2005
46
0.020
Why?
Rats, Sprague-Dawley
1
2009
1581
0.020
Why?
Sodium Chloride
1
2005
58
0.020
Why?
Protein Isoforms
1
2005
118
0.020
Why?
Drug Combinations
1
2005
126
0.020
Why?
Mice, Inbred C57BL
1
2010
1782
0.020
Why?
Antibodies
1
2005
151
0.010
Why?
Statistics, Nonparametric
1
2004
193
0.010
Why?
Reproducibility of Results
1
2007
1195
0.010
Why?
Disease-Free Survival
1
2005
450
0.010
Why?
Platelet Adhesiveness
1
2003
13
0.010
Why?
Elastin
1
2003
23
0.010
Why?
Polytetrafluoroethylene
1
2003
32
0.010
Why?
DNA Primers
1
2003
207
0.010
Why?
Up-Regulation
1
2005
446
0.010
Why?
Radiotherapy
1
2004
124
0.010
Why?
Anastomosis, Surgical
1
2003
66
0.010
Why?
Dogs
1
2003
185
0.010
Why?
Vascular Patency
1
2003
83
0.010
Why?
Radiotherapy, Adjuvant
1
2003
60
0.010
Why?
Myocytes, Smooth Muscle
1
2003
85
0.010
Why?
Chemotherapy, Adjuvant
1
2003
121
0.010
Why?
Extracellular Matrix
1
2003
108
0.010
Why?
Graft Occlusion, Vascular
1
2003
74
0.010
Why?
Thyroidectomy
1
2003
59
0.010
Why?
Biopsy, Needle
1
2003
182
0.010
Why?
Young Adult
1
2012
4052
0.010
Why?
Lymphatic Metastasis
1
2003
226
0.010
Why?
Stromal Cells
1
2002
72
0.010
Why?
Models, Biological
1
2003
722
0.010
Why?
Risk Assessment
1
2003
1255
0.010
Why?
Arkansas
1
2004
1988
0.010
Why?
Diagnosis, Differential
1
2002
1041
0.010
Why?
Pregnancy
1
2003
2609
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description